Global research and development-based biopharmaceutical company, AbbVie, yesterday announced an expansion of its manufacturing facility in Sligo to support the growth of its Oncology pipeline.
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. It employs more than 600 people at five manufacturing and commercial sites across Ireland.
The company’s commercial headquarters is based in Dublin as is a separate international manufacturing and engineering services center. AbbVie has two manufacturing plants in Sligo and one in Cork.
The €113.6 million investment in new sterile manufacturing technology at the Ballytivnan site will help deliver promising treatments for cancers with significant unmet medical needs. The expansion will create approximately 100 new jobs over the course of 3 years in a variety of technical and manufacturing positions. The project is supported by the Government through IDA Ireland.
Welcoming the announcement by AbbVie, Minister for Business, Enterprise and Innovation, Heather Humphreys said, "This is a major investment which will bring 100 new quality jobs and it has the added benefit of being located in the North West Region, which builds on the government's commitment to regional development as part of the Action Plan for Jobs process. This expansion of its operation in Sligo is a great vote of confidence in what that region has to offer."